M. Potgieter

Comparative Pharmacokinetics of a Once‐Daily Tramadol Extended‐Release Tablet and an Immediate‐Release Reference Product Following Single‐Dose and Multiple‐Dose Administration

Maria M Ferreira, C. Fradette, D. Karhu, 2010, Journal of clinical pharmacology.

Carbamazepine and Its Major Metabolites in Plasma: A Summary of Eight Years of Therapeutic Drug Monitoring

H. Hundt, F. Müller, M. A. Potgieter, 1983, Therapeutic drug monitoring.

Biotransformation of insulin glargine after subcutaneous injection in healthy subjects

T. Koose, G U Kuerzel, U Shukla, 2003, Current medical research and opinion.

Dose Proportionality of Once‐Daily Trazodone Extended‐Release Caplets Under Fasting Conditions

D. Mould, D. Karhu, G. Groenewoud, 2010, Journal of clinical pharmacology.

Equipotency of insulin glargine and regular human insulin on glucose disposal in healthy subjects following intravenous infusion

R. Becker, H. Scholtz, S. Pretorius, 2003, Acta Diabetologica.

Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate.

A. Falcão, P. Soares-da-Silva, E. Soares, 2008, International journal of clinical pharmacology and therapeutics.

Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment

P. Soares-da-Silva, J. Maia, L. Almeida, 2008, European Journal of Clinical Pharmacology.

Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus.

B. Campaigne, M. Herz, V. Arora, 2003, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.